Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignanciesJosé María Sánchez‐Pina, María Calbacho, Rodrigo Gil Manso et al.|European Journal Of Haematology|2020Cited by 96
Impact of COVID-19 in patients with multiple myeloma based on a global data networkJoaquín Martínez‐López, Gema Hernández, R. Alonso et al.|Blood Cancer Journal|2021Cited by 59
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple MyelomaAlba Rodríguez-García, María Linares, Andrés Arroyo et al.|Clinical Cancer Research|2023Cited by 59
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemiaMaribel Forero‐Castro, Jesús María Hernández‐Rivas, Cristina Robledo et al.|British Journal of Cancer|2017Cited by 51
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluidRicardo Sánchez, Joaquín Martínez‐López, Rosa Ayala et al.|Annals of Hematology|2017Cited by 30